Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma - Concepedia

Concepedia

Publication | Open Access

Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma

DOI Full Paper Access

86

Citations

37

References

2010

Year

Karen K. Cham, Jennifer H.E. Baker, Karam S. Takhar, Jennifer A. Flexman, May Q. Wong, David Owen, Andrew Yung, Stefan A. Reinsberg, Edward Chu, C-W A Chang,

British Journal of Cancer

Abstract

Metronomic dosing of gemcitabine is active in pancreatic cancer and is accompanied by pronounced changes in the tumour microenvironment.

References

	Year	Citations

Page 1